Generalized pustular drug eruptions: Confirmation by in vitro tests

Journal of the European Academy of Dermatology and Venereology

Volumn 10, Issue 1, 1998, Pages 36-41

  Lazarov, A ^a   Livni, E ^b   Halevy, S ^c  

^a MEIR MEDICAL CENTER   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Acute generalized exanthematous pustulosis; Drug eruption; In vitro tests; Pustular; Toxic pustulosis

Indexed keywords

AMPICILLIN; CEFAZOLIN; ENALAPRIL MALEATE; GRISEOFULVIN; TETRACYCLINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG ERUPTION; EOSINOPHILIA; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERIMMUNOGLOBULINEMIA E; HYPERTENSION; INFLAMMATORY INFILTRATE; KERATOSIS; MALE; MAST CELL DEGRANULATION; NEUTROPHILIA; PNEUMONIA; PRIORITY JOURNAL; ROSACEA; SKIN BIOPSY;

ADULT; DRUG ERUPTIONS; FEMALE; HUMANS; IMMUNOLOGIC TECHNIQUES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MAST CELLS; MIDDLE AGED; SKIN DISEASES, VESICULOBULLOUS;

EID: 0031932764     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0926-9959(97)00141-4     Document Type: Article

References (46)

1. Stevanovic DV. Pustular eruption with eosinophilic abscesses. Br J Dermatol 1971;85:134-139.
2. MacMillan AL. Generalized pustular drug rash. Dermatologica 1973;146: 285-291.
3. Staughton RCD, Harper JI, Rowland Payne CME, et al. Toxic pustuloderma - a new entity?, J R Soc Med 1984;77:6-8.
4. Jackson H, Vion B, Levy PM. Generalized eruptive pustular drug rash due to cephalexin. Dermatologica 1988;177:292-294.
5. Tousignant J, Allaire G. Drug induced toxic pustuloderma. Int J Dermatol 1992;31:172-174.
6. Beylot C, Bioulac P, Doutre MS. Pustuloses exanthématiques aiguës généralisées. A propos de 4 cas. Ann Dermatol Venereol 1980;107:37-48.
7. Roujeau JC, Bioulac-Sage P, Bourseau C, et al. Acute generalized exanthematous pustulosis. Arch Dermatol 1991;127:1333-1338.
8. Gebauer K, Holgate C, Navaratnam A. Toxic pustuloderma. Australas Dermatol 1990;31:89-93.
9. Shelly ED, Shelly WB. The subcorneal pustular drug eruption: an example induced by norfloxacin. Cutis 1988;42:24-27.
10. Trueb RM, Burg G. Acute generalized exanthematous pustulosis due to doxycycline. Dermatology 1993;186:75-78.
11. Livni E, Halevy S, Stahl B, et al. The appearance of macrophage migration inhibition factor in drug reactions. J Allergy Clin Immunol 1987;80:843-849.
12. Schwartz J, Klopstock A, Zikert-Duvdevani P, et al. Detection of hypersensitivity by indirect rat mast cell degranulation. Int Arch Allergy 1965;26:333-339.
13. Spencer JM, Silvers DN, Grossman ME. Pustular eruption after drug exposure: is it pustular psoriasis or a pustular drug eruption?, Br J Dermatol 1994;130:514-519.
14. Yu RCH, Chu TC. Allopurinol-induced toxic pustuloderma. Br J Dermatol 1993;128:95-98.
15. Ogoshi M, Yamada Y, Tani M. Acute generalized exanthematic pustulosis induced by cefaclor and acetazolamide. Dermatology 1992;184:142-144.
16. Fitzgerald DA, Heagerty AHM, Stephens M, et al. Follicular toxic pustuloderma associated with allopurinol. Clin Exp Dermatol 1994;19:243-245.
17. Heymann WR, Manders SM. Itraconazole-induced acute generalized exanthematic pustulosis. J Am Acad Dermatol 1995;33:130-131.
18. Mota I, Silva WD. Antigen induced damage to isolated sensitized mast cells. Nature 1960;186:245-246.
19. Tanay A, Yust I, Brenner S, et al. Dermal vasculitis due to coumadin hypersensitivity. Dermatologica 1982;165:178-185.
20. Halevy S, Ingber A, Feuerman EJ. Subcorneal pustulosis - an unusual course. Acta Dermatol Venereol (Stockh) 1983;63:441-444.
21. Grunwald MH, Halevy S, Livni E. Allergic vasculitis induced by hydrochlorothiazide: confirmation by mast cell degranulation test. Isr J Med Sci 1989;25:572-574.
22. Halevy S, Grunwald MH, Sandbank M, et al. Macrophage migration inhibition factor (MIF) in drug eruption. Arch Dermatol 1990;126:48-51.
23. Wolf R, Livni E, Joshua H. Concurrent cell-mediated immunity and immediate hypersensitivity in animal model. Ann Allergy 1984;52:300-302.
24. Halevy S, Grunwald MH, Sandbank M, et al. Macrophage migration inhibition factor (MIF) as a diagnostic aid in drug eruptions. Harefuha 1991;121:147-149.
25. Halevy S, Livni E. Psoriasis and psoriasiform eruptions associated with propranolol: the role of an immunologic mechanism. Arch Dermatol Res 1991;283:472-473.
26. Halevy S, Sandbank M, Livni E. Macrophage migration inhibition factor release in lichenoid drug eruptions. J Am Acad Dermatol 1993;29: 263-265.
27. Grattan CEH. Generalized eruptive pustular rash due to naproxen. Dermatologica 1989;179:57-58.
28. Diaz LA, Provost TT, Tomasi TB. Pustular necrotizing angiitis. Arch Dermatol 1973;108:114-118.
29. Armster H, Schwarz T. Arzneimittelreaktion auf Amoxicillin unter dem Bild eines toxischen Pustuloderms. Hautarzt 1991;42:713-716.
30. Ogino A, Tagami H, Takashi C, et al. Generalized pustular toxic erythema: pathogenetic relationship between pustule and epidermal appendage (hair follicle or sweat duct). Acta Dermatol Venereol 1978;58:257-261.
31. Stough D, Guin JD, Baker GF, et al. Pustular eruptions following administration of cefazolin: a possible interaction with methyldopa. J Am Acad Dermatol 1987;16:1051-1052.
32. Fayol J, Bernard P, Bonnetblanc JM. Pustular eruption following administration of cefazolin; a second case report. J Am Acad Dermatol 1988;19:571.
33. Kalb RE, Grossman ME. Pustular eruption following administration of Cephradine. Cutis 1986;38:58-60.
34. Röckl H. Medikamentenallergische Vasculitis leucocytoclastica unter dem Build eines generalisierten pustulösen Exanthems. Hautarzt 1981;32:467-470.
35. MacDonald KJS. Pustular dermatosis induced by cotrimoxazole. Br J Dermatol 1986;293:1279-1280.
36. Escallier F, Dalac S, Foucher JL, et al. Pustulose exanthématique aiguë généralisée. Imputabilit à l'imipéneme (Tiénam®). Ann Dermatol Venereol 1989;116:407-409.
37. Yamasaki R, Yamasaki M, Kawasaki Y, et al. Generalized pustular dermatosis caused by isoniacid. Br J Dermatol 1985;112:504-506.
38. Braun-Falco O, Luderschmidt C, Maciejewski W, et al. Pustulosis acuta generalisata. Hautarzt 1978;29:371-377.
39. Kushimoto H, Aoki T. Toxic erythema with generalized follicular pustules caused by streptomycin. Arch Dermatol 1981;117:444-445.
40. Commens CA, Fischer GO. Toxic pustuloderma following carbamazepine therapy. Arch Dermatol 1988;124:178-179.
41. Stanley J. Phenytoin hypersensitivity reaction. Arch Dermatol 1978;114:1350-1353.
42. Lambert DG, Dalac S, Beer F, et al. Acute generalized exanthematous pustular dermatitis induced by diltiazem. Br J Dermatol 1988;118:308-309.
43. Lotem M, Ingber A, Segal R, et al. Generalized pustular drug rash induced by hydroxychloroquine. Acta Dermatol Venereol 1990;70:250-251.
44. Spindler E, Janier M, Bonnin JM, et al. Pustulose exanthématique aiguë généralisée liée à la buphénine: un cas. Ann Dermatol Venereol 1992;119:273-275.
45. Yip J, Sheehan-Dare R, Cottrill J. Toxic pustuloderma due to PUVA treatment. Br J Dermatol 1991;125:401-402.
46. Bernard P, Bedane C, Catanzano G, et al. Acute generalized exanthematic pustulosis. An atypical case due to nadoxolol?, Dermatologica 1991;182:115-118.